Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma – Oncology Nurse Advisor


Oncology Nurse Advisor

Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
Oncology Nurse Advisor
Whole-exome sequencing of tumor biopsies from metastatic melanoma taken before, during, and after treatment with sequential checkpoint blockade against cytotoxic T lymphocyte antigen-4 (CTLA-4) followed by programmed death receptor-1 (PD-1) …

Source: Genome Sequencing